FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4372411000001106: Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26972101000001117 Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
72643301000001117 Zantac 75 Relief Dissolve tablets (Omega Pharma Ltd) 12 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Is a Ranitidine 75mg effervescent tablets sugar free 12 tablet true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Is pack of Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has manufactured dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has AMP Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Relief Dissolve effervescent tablets (GlaxoSmithKline) 12 tablet Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start